Earlier this month, Dr. David Jarrard was named Deputy Director of the UW Carbone Cancer Center. A tenured professor and Vice Chair of the Department of Urology and the John P. Livesey Chair in Urologic Oncology, Dr. Jarrard also serves as Associate Director for Translational Research for UW Carbone and is a member of the Wisconsin Institutes for Discovery Epigenetics program. He is a long-standing, independently-funded physician-scientist with expertise in clinical urologic cancer management, clinical trials, and translational research. Dr. Jarrard’s research teams examine epigenetic factors underlying prostate cancer progression and novel approaches to treating advanced disease.
“It’s a true honor to have David in this role, based on his vast experience within the cancer realm at UW Carbone,” said Howard Bailey, MD, UW Carbone Cancer Center director. “Undoubtedly, his leadership in this role will help us exponentially as we continue to leverage our translational cancer research efforts.”
“It’s a true honor to have David in this role, based on his vast experience within the cancer realm at UW Carbone,” said Howard Bailey, MD, UW Carbone Cancer Center director. “Undoubtedly, his leadership in this role will help us exponentially as we continue to leverage our translational cancer research efforts.”
Nationally, Dr. Jarrard has held several distinguished positions, including serving on the Department of Defense Prostate Cancer Research Program integration panel and cancer guidelines panels for the National Comprehensive Cancer Network (NCCN) and the American Urological Association. He has had leadership roles within the Society for Urologic Oncology and served as President of the North Central Section of the American Urological Association, the Society for Academic Urology, and the Society for Basic Urologic Research.
Jarrard earned his undergraduate and medical school degrees at the University of Virginia. He completed his residency at the University of Chicago and a two-year fellowship in urologic oncology at the American Foundation for Urologic Disease, Johns Hopkins University, before joining the UW School of Medicine and Public Health faculty.
This post was adapted from an announcement by the UW Carbone Cancer Center.